Search clinical trials for: Triptorelin pamoate

Total 255 results

Ipsen

Completed

Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

Endometriosis

China
Universitaire Ziekenhuizen KU Leuven
Ipsen

Recruiting

Long-term Better Than Short-term ADT With Salvage RT (LOBSTER)

Prostate Cancer

Belgium
Ipsen

Completed

Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

Central Precocious Puberty

China
Ipsen

Completed

Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer (DKP 3M SC)

Prostate Cancer

Poland, Romania, Bulgaria, Latvia, France
Ipsen

Active, not recruiting

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Metastatic Prostate Cancer | Advanced Prostate Cancer | Locally Advanced Prostate Cancer

China
Ipsen

Completed

Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty (DECAPUB)

Precocious Puberty

France
Aristotle University Of Thessaloniki
Eugonia IVF Unit, Athens, Greece

Unknown

Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients (ATD)

Subfertility

Greece
Ipsen

Completed

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg (PAMIS)

Prostate Cancer

Germany
Children's Hospital Medical Center, Cincinnati
Watson Pharmaceuticals

Completed

Triptorelin for Ovary Protection in Childhood Onset Lupus

Systemic Lupus Erythematosus

United States, Brazil
National Taiwan University Hospital
Debiopharm International SA; Ministry of Health and Welfare

Not yet recruiting

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients (ESCALATE)

Triple Negative Breast Cancer | Premenopausal Breast Cancer
Watson Pharmaceuticals

Completed

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Prostate Cancer

United States
Nanjing University

Unknown

Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI

Polycystic Ovary Syndrome | In Vitro Fertilization

China
Chenshiling
National Natural Science Foundation of China; Comprehensive Strategic Cooperation... and other collaborators

Unknown

Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome

Infertility and at High Risk of OHSS

China
Kaunas University of Medicine

Unknown

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

Prostate Cancer

Lithuania
Masaryk University
Ministry of Health, Czech Republic

Completed

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients (OVARONKO)

Hodgkin Disease | Hodgkin Lymphoma

Czech Republic
Tampere University Hospital

Completed

Luteal Phase Support in Insemination Cycles

Infertility, Female

Finland
Parc de Salut Mar

Completed

Generation of Biological Samples Positive to Triptorelin for Anti-doping Control (TRIPTO)

Healthy Volunteers

Spain
Pharmatech
Watson Pharmaceuticals; Manyak, Michael, M.D.

Terminated

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Prostate Cancer

United States
Ipsen

Terminated

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

Prostate Cancer

Netherlands
Benha University

Unknown

Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

Infertility, Female

Egypt
HaEmek Medical Center, Israel

Completed

Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

Infertility

Israel
Alphamab Jilin Co., Ltd.

Unknown

Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers

Infertility, Female

China
Azienda Ospedaliera S. Maria della Misericordia

Completed

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Uterine Myoma

Italy
Ipsen

Completed

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study (DECAPUB)

Precocious Puberty

France
Chenshiling
National Natural Science Foundation of China; Comprehensive Strategic Cooperation... and other collaborators

Unknown

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

Infertility and at High Risk of OHSS

China
Universitair Ziekenhuis Brussel
Universitaire Ziekenhuizen KU Leuven

Recruiting

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (Depo-Trigger)

Breast Cancer Female

Belgium
Armando Santoro, MD

Terminated

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Breast Cancer

Italy
Immune System Regulation AB

Unknown

Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

HIV-1-infection

Sweden, Germany
Mansoura University

Recruiting

GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles

Infertility

Egypt
American University of Beirut Medical Center

Completed

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

Infertility | Sterility

Lebanon
Herlev Hospital

Completed

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Fatty Liver | Metabolic Syndrome | Prostate Cancer | Hypogonadism

Denmark
V.K.V. American Hospital, Istanbul

Terminated

Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles

Infertility

Turkey
Mansoura University

Recruiting

GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles

Infertility

Egypt
Ipsen

Completed

A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. (PRIORITI)

Prostate Cancer

China, Russian Federation
Ipsen

Completed

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer (Triptocare)

Prostate Cancer

Spain, Belgium, Netherlands, France, United Kingdom, Denmark, Latvia, Lithuania, Romania, Italy
Debiopharm International SA

Completed

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

Prostatic Neoplasm

South Africa
Bart CJM Fauser

Terminated

A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)

In Vitro Fertilization

Netherlands
Assistance Publique - Hôpitaux de Paris

Unknown

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (PRESOV)

Sarcoma | Lymphoma | Cancer | Osteosarcoma | Ewing Sarcoma | Toxicity Due to Chemotherapy

France
Elisha Hospital
Merck Sharp & Dohme LLC

Terminated

Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

Ovarian Hyperstimulation Syndrome

Israel
Ipsen

Terminated

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer (ANABRAQ)

Prostate Cancer

Spain
SOLTI Breast Cancer Research Group

Recruiting

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer (SOLTI-2104)

Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast Cancer

Spain
University of South Florida
National Cancer Institute (NCI)

Terminated

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Breast Cancer | Drug Toxicity | Hormone Changes

United States
Debiopharm International SA

Completed

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

Central Precocious Puberty

United States, Chile, Mexico
Centre Hospitalier Universitaire Ibn Rochd

Completed

GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT (GTMLPSGI)

Infertility

Algeria
Universitair Ziekenhuis Brussel

Completed

Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

Infertility | Poor Ovarian Response

Belgium
Instituto de Investigacion Sanitaria La Fe

Completed

The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis (ENDOFIV)

Infertility | Endometriosis

Spain
Belgian Study Group for Pediatric Endocrinology

Active, not recruiting

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height (ZomaTrip)

Idiopathic Short Stature

Belgium
Debiopharm International SA
Quintiles, Inc.

Completed

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

Prostate Cancer

South Africa
Ipsen

Active, not recruiting

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate (TriptoSwitch)

Prostate Cancer

Spain, Lithuania, Germany, France, Belgium, Netherlands, Czechia
Centre Hospitalier Universitaire Ibn Rochd

Completed

GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

Infertility

Algeria

3

Subscribe